Skip to main content

Celiac Disease Screening for High-Risk Groups: Are We Doing It Right?

Digestive Diseases and Sciences volume 65, pages 2187–2195 (2020)Cite this article

A Correction to this article was published on 04 July 2020

This article has been updated

Abstract

Celiac disease (CD) is an immune-mediated enteropathy triggered by dietary ingestion of gluten in genetically susceptible patients. CD is often diagnosed by a “case-finding” approach of symptomatic patients. In recent times, the diagnostic paradigm has shifted to investigate patients who may be asymptomatic, but are at high risk of developing CD due to shared genetic susceptibilities. These high-risk groups include first-degree relatives of CD patients and patients with Type 1 diabetes mellitus, autoimmune thyroid disease, Down’s syndrome, and Turner syndrome. Moreover, CD is often diagnosed as the cause of iron deficiency anemia or unexplained chronic diarrhea. Although screening for CD with serological tests is not recommended for the general population, it should be considered in these special populations. In this review, we explore screening for CD among high-risk groups in light of recent research and development in the CD arena.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price includes VAT (USA)
Tax calculation will be finalised during checkout.

Fig. 1

Change history

  • 04 July 2020

    The original version of the article is unfortunately missing the funding information. Funding note is given below.

References

  1. Singh P, Arora A, Strand TA, et al. Global prevalence of celiac disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2018;16:823–836.

    PubMed  Google Scholar 

  2. Dubé C, Rostom A, Sy R, et al. The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review. Gastroenterology. 2005;128:S57–S67.

    PubMed  Google Scholar 

  3. Catassi C, Kryszak D, Bhatti B, et al. Natural history of celiac disease autoimmunity in a USA cohort followed since 1974. Ann Med. 2010;42:530–538.

    PubMed  Google Scholar 

  4. Rubio-Tapia A, Kyle RA, Kaplan EL, et al. Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology. 2009;137:88–93.

    PubMed  PubMed Central  Google Scholar 

  5. Choung RS, Ditah IC, Nadeau AM, et al. Trends and racial/ethnic disparities in gluten-sensitive problems in the United States: findings from the National Health and Nutrition Examination Surveys from 1988 to 2012. Am J Gastroenterol. 2015;110:455–461.

    PubMed  Google Scholar 

  6. Hin H, Bird G, Fisher P, Mahy N, Jewell D. Coeliac disease in primary care: case finding study. Br Med J. 1999;318:164–167.

    CAS  Google Scholar 

  7. Sanders DS, Patel D, Stephenson TJ, et al. A primary care cross-sectional study of undiagnosed adult coeliac disease. Eur J Gastroenterol Hepatol. 2003;15:407–413.

    CAS  PubMed  Google Scholar 

  8. West J, Logan RFA, Hill PG, Khaw K-T. The iceberg of celiac disease: what is below the waterline? Clin Gastroenterol Hepatol. 2007;5:59–62.

    CAS  PubMed  Google Scholar 

  9. Choung RS, Larson SA, Khaleghi S, et al. Prevalence and morbidity of undiagnosed celiac disease from a community-based study. Gastroenterology. 2017;152:830–839.

    PubMed  Google Scholar 

  10. Hujoel IA, Van Dyke CT, Brantner T, et al. Natural history and clinical detection of undiagnosed coeliac disease in a North American community. Aliment Pharmacol Ther. 2018;47:1358–1366. https://doi.org/10.1111/apt.14625.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  11. Silano M, Volta U, Mecchia A, et al. Delayed diagnosis of coeliac disease increases cancer risk. BMC Gastroenterol. 2007;7:8.

    PubMed  PubMed Central  Google Scholar 

  12. Catassi C, Kryszak D, Louis-Jacques O, et al. Detection of celiac disease in primary care: a multicenter case-finding study in North America. Am J Gastroenterol. 2007;102:1454–1460.

    PubMed  Google Scholar 

  13. Husby S, Koletzko S, Korponay-Szabó I, et al. Hepatology and nutrition guidelines for diagnosing coeliac disease 2020. J Pediatr Gastroenterol Nutr. 2020;70:141–156.

    PubMed  Google Scholar 

  14. Rubio-Tapia A, Hill ID, Kelly CP, Calderwood AH, Murray JA. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol. 2013;108:656–676.

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Herman C. Virtual mentor clinical pearl what makes a screening exam “good”? Ethics J Am Med Assoc. 2006. 8. www.virtualmentor.org

  16. Green PHR, Stavropoulos SN, Panagi SG, et al. Characteristics of adult celiac disease in the USA: results of a national survey. Am J Gastroenterol. 2001;96:126–131.

    PubMed  Google Scholar 

  17. Lo W, Sano K, Lebwohl B, Diamond B, Green PHR. Changing presentation of adult celiac disease. Dig Dis Sci. 2003;48:395–398.

    PubMed  Google Scholar 

  18. Bibbins-Domingo K, Grossman DC, Curry SJ, et al. Screening for celiac disease: US preventive services task force recommendation statement. JAMA J Am Med Assoc. 2017;317:1252–1257.

    Google Scholar 

  19. Hill ID, Dirks MH, Liptak GS, et al. Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2005;40:1–19.

    PubMed  Google Scholar 

  20. Coeliac disease: recognition, assessment and management NICE guideline. 2015. www.nice.org.uk/guidance/ng20

  21. Tovoli F, Negrini G, Sansone V, Faggiano C, Catenaro T, Bolondi L, et al. Celiac disease diagnosed through screening programs in at-risk adults is not associated with worse adherence to the gluten-free diet and might protect from osteopenia/osteoporosis. 2018. www.mdpi.com/journal/nutrients.

  22. Lebwohl B, Rubio-Tapia A, Guandalini S, Newland C, Assiri A. Diagnosis of celiac disease. Gastrointest Endosc Clin N Am. 2012;22(4):661.

    PubMed  PubMed Central  Google Scholar 

  23. Rostom A, Dubé C, Cranney A, et al. The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology. 2005;128:S38–S46.

    PubMed  Google Scholar 

  24. Dieterich W, Ehnis T, Bauer M, et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med. 1997;3:797–801.

    CAS  PubMed  Google Scholar 

  25. Troncone R, Maurano F, Rossi M, et al. IgA antibodies to tissue transglutaminase: an effective diagnostic test for celiac disease. J Pediatr. 1999;134:166–171.

    CAS  PubMed  Google Scholar 

  26. Dieterich W, Laag E, Schopper H, et al. Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology. 1998;115:1317–1321.

    CAS  PubMed  Google Scholar 

  27. Grodzinsky E, Hed J, Skogh T. IgA antiendomysium antibodies have a high positive predictive value for celiac disease in asymptomatic patients. Allergy. 1994;49:593–597.

    CAS  PubMed  Google Scholar 

  28. Latiff AHA, Kerr MA. The clinical significance of immunoglobulin A deficiency. Ann Clin Biochem. 2007;44:131–139.

    PubMed  Google Scholar 

  29. McGowan KE, Lyon ME, Butzner JD. Celiac disease and IgA deficiency: complications of serological testing approaches encountered in the clinic. Clin Chem. 2008;54:1203–1209.

    CAS  PubMed  Google Scholar 

  30. Lenhardt A, Plebani A, Marchetti F, et al. Role of human-tissue transglutaminase IgG and anti-gliadin IgG antibodies in the diagnosis of coeliac disease in patients with selective immunoglobulin A deficiency. Dig Liver Dis. 2004;36:730–734.

    CAS  PubMed  Google Scholar 

  31. Villalta D, Tonutti E, Prause C, et al. IgG antibodies against deamidated gliadin peptides for diagnosis of celiac disease in patients with IgA deficiency. Clin Chem. 2010;56:464–468.

    CAS  PubMed  Google Scholar 

  32. Leffler D, Schuppan D, Pallav K, et al. Kinetics of the histological, serological and symptomatic responses to gluten challenge in adults with coeliac disease. Gut. 2013;62:996–1004.

    CAS  PubMed  Google Scholar 

  33. Brown NK, Guandalini S, Semrad C, Kupfer SS. A clinician’s guide to celiac disease HLA genetics. Am J Gastroenterol. 2019;114:1587–1592.

    PubMed  Google Scholar 

  34. Almeida LM, Gandolfi L, Pratesi R, et al. Presence of DQ2.2 associated with DQ2.5 increases the risk for celiac disease. Autoimmune Dis. 2016;2016:5409653.

    PubMed  PubMed Central  Google Scholar 

  35. Fasano A, Berti I, Gerarduzzi T, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med. 2003;163:286–292.

    PubMed  Google Scholar 

  36. Rubio-Tapia A, Van Dyke CT, Lahr BD, et al. Predictors of family risk for celiac disease: a population-based study. Clin Gastroenterol Hepatol. 2008;6:983–987.

    PubMed  PubMed Central  Google Scholar 

  37. Nellikkal SS, Hafed Y, Larson JJ, Murray JA, Absah I. High prevalence of celiac disease among screened first-degree relatives. Mayo Clin Proc. 2019;94:1807–1813. https://doi.org/10.1016/j.mayocp.2019.03.027.

    Article  PubMed  Google Scholar 

  38. Emilsson L, Wijmenga C, Murray JA, Ludvigsson JF. Autoimmune disease in first-degree relatives and spouses of individuals with celiac disease. Clin Gastroenterol Hepatol. 2015;13(1271–1277):e2.

    PubMed  Google Scholar 

  39. Wessels MMS, de Rooij N, Roovers L, Verhage J, de Vries W, Mearin ML. Towards an individual screening strategy for first-degree relatives of celiac patients. Eur J Pediatr. 2018;177:1585–1592.

    PubMed  Google Scholar 

  40. Maahs DM, West NA, Lawrence JM, Mayer-Davis EJ, Davis B. Chapter 1: epidemiology of type 1 diabetes. Endocrinol Metab Clin. 2010;39:481–497.

    Google Scholar 

  41. Kylökäs A, Kaukinen K, Huhtala H, Collin P, Mäki M, Kurppa K. Type 1 and type 2 diabetes in celiac disease: prevalence and effect on clinical and histological presentation. BMC Gastroenterol. 2016;16:76. https://doi.org/10.1186/s12876-016-0488-2.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  42. Craig ME, Prinz N, Boyle CT, et al. Prevalence of celiac disease in 52,721 youth with type 1 diabetes: international comparison across three continents. Diabetes Care. 2017;40:1034–1040.

    PubMed  PubMed Central  Google Scholar 

  43. Smigoc Schweiger D, Mendez A, Kunilo Jamnik S, et al. High-risk genotypes HLA-DR3-DQ2/DR3-DQ2 and DR3-DQ2/DR4-DQ8 in co-occurrence of type 1 diabetes and celiac disease. Autoimmunity. 2016;49:240–247.

    CAS  PubMed  Google Scholar 

  44. Larsson K, Carlsson A, Cederwall E, et al. Annual screening detects celiac disease in children with type 1 diabetes. Pediatr Diabetes. 2008;9:354–359. https://doi.org/10.1111/j.1399-5448.2008.00367.x.

    Article  PubMed  Google Scholar 

  45. Lunt H, Florkowski CM, Cundy T, et al. A population-based study of bone mineral density in women with longstanding Type 1 (insulin dependent) diabetes. Diabetes Res Clin Pract. 1998;40:31–38.

    CAS  PubMed  Google Scholar 

  46. Neu A, Ehehalt S, Willasch A, Kehrer M, Hub R, Ranke MB. Rising incidence of type 1 diabetes in Germany: 12-year trend analysis in children 0–14 years of age. Diabetes Care. 2001;24(4):785–786.

    CAS  PubMed  Google Scholar 

  47. Diniz-Santos DR, Brandão F, Adan L, Moreira A, Vicente EJ, Silva LR. Bone mineralization in young patients with type 1 diabetes mellitus and screening-identified evidence of celiac disease. Dig Dis Sci. 2008;53:1240–1245.

    PubMed  Google Scholar 

  48. Leeds JS, Hopper AD, Hadjivassiliou M, Tesfaye S, Sanders DS. High prevalence of microvascular complications in adults with type 1 diabetes and newly diagnosed celiac disease. Diabetes Care. 2011;34:2158–2163.

    PubMed  PubMed Central  Google Scholar 

  49. Tsouka A, Mahmud FH, Marcon MA. Celiac disease alone and associated with type 1 diabetes mellitus. J Pediatr Gastroenterol Nutr. 2015;61:297–302.

    CAS  PubMed  Google Scholar 

  50. Pham-Short A, Gcdem H-I, Donaghue KC, et al. Screening for celiac disease in type 1 diabetes: a systematic review. Rev Artic Pediatr. 2015;. https://doi.org/10.1542/peds.2014-2883.

    Article  Google Scholar 

  51. Hanley P, Lord K, Bauer AJ. Thyroid disorders in children and adolescents: a review. JAMA Pediatr. 2016;170:1008–1019.

    PubMed  Google Scholar 

  52. Kahaly GJ, Frommer L, Schuppan D. Celiac disease and endocrine autoimmunity—the genetic link. Autoimmun Rev. 2018;17:1169–1175.

    CAS  PubMed  Google Scholar 

  53. Sategna-Guidetti C, Volta U, Ciacci C, et al. Prevalence of thyroid disorders in untreated adult celiac disease patients and effect of gluten withdrawal: an Italian multicenter study. Am J Gastroenterol. 2001;96:751–757. https://doi.org/10.1111/j.1572-0241.2001.03617.x.

    CAS  Article  PubMed  Google Scholar 

  54. Meloni GF, Tomasi PA, Bertoncelli A, Fanciulli G, Delitala G, Meloni T. Prevalence of silent celiac disease in patients with autoimmune thyroiditis from Northern Sardinia. J Endocrinol Invest. 2001;24:298–302.

    CAS  PubMed  Google Scholar 

  55. Larizza D, Calcaterra V, De Giacomo C, et al. Celiac disease in children with autoimmune thyroid disease. J Pediatr. 2001;139:738–740.

    CAS  PubMed  Google Scholar 

  56. Canova C, Pitter G, Ludvigsson JF, et al. Celiac disease and risk of autoimmune disorders: a population-based matched birth cohort study. J Pediatr. 2016;174:146–152.

    PubMed  Google Scholar 

  57. Reilly NR, Verma R. Time to screen children with celiac disease for thyroid disease? J Pediatr. 2016;174:7–9.

    PubMed  Google Scholar 

  58. Ch’ng CL, Biswas M, Benton A, Jones MK, Kingham JGC. Prospective screening for coeliac disease in patients with Graves’ hyperthyroidism using anti-gliadin and tissue transglutaminase antibodies. Clin Endocrinol (Oxf). 2005;62:303–306. https://doi.org/10.1111/j.1365-2265.2005.02214.x.

    Article  PubMed  Google Scholar 

  59. Virili C, Bassotti G, Santaguida MG, et al. Atypical celiac disease as cause of increased need for thyroxine: a systematic study. J Clin Endocrinol Metab. 2012;97:E419–E422.

    CAS  PubMed  Google Scholar 

  60. Kassebaum NJ, Jasrasaria R, Naghavi M, et al. A systematic analysis of global anemia burden from 1990 to 2010. Blood. 2014;123:615–624.

    CAS  PubMed  PubMed Central  Google Scholar 

  61. Camaschella C. Iron-deficiency anemia. N Engl J Med. 2015;372:1832–1843.

    PubMed  Google Scholar 

  62. Yanatori I, Kishi F. DMT1 and iron transport. Free Radic Biol Med. 2019;133:55–63.

    CAS  PubMed  Google Scholar 

  63. Hershko C, Camaschella C. How I treat unexplained refractory iron deficiency anemia. Blood. 2014;123:326–333.

    CAS  PubMed  Google Scholar 

  64. Mahadev S, Laszkowska M, Sundström J, et al. Prevalence of celiac disease in patients with iron deficiency anemia—a systematic review with meta-analysis. Gastroenterology. 2018;155:374–382.

    PubMed  PubMed Central  Google Scholar 

  65. Harper JW, Holleran SF, Ramakrishnan R, Bhagat G, Green PHR. Anemia in celiac disease is multifactorial in etiology. Am J Hematol. 2007;82:996–1000. https://doi.org/10.1002/ajh.20996.

    Article  PubMed  Google Scholar 

  66. Repo M, Lindfors K, Mäki M, et al. Anemia and iron deficiency in children with potential celiac disease. J Pediatr Gastroenterol Nutr. 2017;64:56–62.

    CAS  PubMed  Google Scholar 

  67. Hershko C, Hoffbrand AV, Keret D, et al. Role of autoimmune gastritis, Helicobacter pylori and celiac disease in refractory or unexplained iron deficiency anemia. Haematologica. 2005;90:585–595.

    CAS  PubMed  Google Scholar 

  68. Ransford RAJ, Hayes M, Palmer M, Hall MJ. A controlled, prospective screening study of celiac disease presenting as iron deficiency anemia. J Clin Gastroenterol. 2002;35:228–233.

    CAS  PubMed  Google Scholar 

  69. Lacy BE, Mearin F, Chang L, et al. Bowel disorders. Gastroenterology. 2016;150:1393–1407.

    Google Scholar 

  70. Lovell RM, Ford AC. Global prevalence of and risk factors for irritable Bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol. 2012;10:712–721.

    PubMed  Google Scholar 

  71. Halmos EP, Power VA, Shepherd SJ, Gibson PR, Muir JG. A diet low in FODMAPs reduces symptoms of irritable Bowel syndrome. Gastroenterology. 2014;146:67–75.

    CAS  PubMed  Google Scholar 

  72. Shahbazkhani B, Sadeghi A, Malekzadeh R, et al. Non-celiac gluten sensitivity has narrowed the spectrum of irritable Bowel syndrome: a double-blind randomized placebo-controlled trial. Nutrients. 2015;7:4542–4554.

    CAS  PubMed  PubMed Central  Google Scholar 

  73. Skodje GI, Sarna VK, Minelle IH, et al. Fructan, rather than gluten, induces symptoms in patients with self-reported non-celiac gluten sensitivity. Gastroenterology. 2018;154:529–539.

    CAS  PubMed  Google Scholar 

  74. Ford AC, Chey WD, Talley NJ, Malhotra A, Spiegel BMR, Moayyedi P. Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome systematic review and meta-analysis. Arch Intern Med. 2009;169:651–658.

    PubMed  Google Scholar 

  75. Irvine AJ, Chey WD, Ford AC. Screening for celiac disease in irritable Bowel syndrome: an updated systematic review and meta-analysis. Am J Gastroenterol. 2017;112:65–76.

    PubMed  Google Scholar 

  76. Smalley W, Falck-Ytter C, Carrasco-Labra A, Wani S, Lytvyn L, Falck-Ytter Y. AGA clinical practice guidelines on the laboratory evaluation of functional diarrhea and diarrhea-predominant irritable bowel syndrome in adults (IBS-D). Gastroenterology. 2019;. https://doi.org/10.1053/j.gastro.2019.07.004.

    Article  PubMed  Google Scholar 

  77. Spiegel BMR, Derosa VP, Gralnek IM, Wang V, Dulai GS. Testing for Celiac Sprue in Irritable Bowel Syndrome With Predominant Diarrhea: A Cost-Effectiveness Analysis. 2004;

  78. Mein SM, Ladabaum U. Serological testing for coeliac disease in patients with symptoms of irritable bowel syndrome: a cost-effectiveness analysis. Aliment Pharmacol Ther. 2004;19:1199–1210. https://doi.org/10.1111/j.1365-2036.2004.01958.x.

    CAS  Article  PubMed  Google Scholar 

  79. Mohseninejad L, Feenstra T, Van Der Horst HE, Woutersen-Koch L, et al. Targeted screening for coeliac disease among irritable bowel syndrome patients: analysis of cost-effectiveness and value of information. Eur J Health Econ. 2013;14:947–957.

    PubMed  Google Scholar 

  80. Bharucha A, Dorn S, Lembo A, Pressman A. AGA American Gastroenterological Association Medical Position Statement on Constipation. Gastroenterological Association A. Gastroenterology. 2013;. https://doi.org/10.1053/j.gastro.2012.10.029.

    Article  PubMed  PubMed Central  Google Scholar 

  81. Zone JJ. Skin manifestations of celiac disease. Gastroenterology. 2005;128:S87–S91.

    PubMed  Google Scholar 

  82. Kelly CP. Celiac Disease and Refractory Celiac Disease. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtran’s Gastrointestinal and Liver Disease. United Kingdom: Elsevier Health Science; 2010. p. 1797–1820.

  83. Bolotin D, Petronic-Rosic V. Dermatitis herpetiformis: part I. Epidemiology, pathogenesis, and clinical presentation. J Am Acad Dermatol. 2011;64:1017–1024.

    PubMed  Google Scholar 

  84. Spurkland A, Ingvarsson G, Falk ES, Knutsen I, Sollid LM, Thorsby E. Dermatitis herpetiformis and celiac disease are both primarily associated with the HLA-DQ (α1*0501, (β1*02) or the HLA-DQ (α1*03, (β1*0302) heterodimers. Tissue Antigens. 1997;49:29–34. https://doi.org/10.1111/j.1399-0039.1997.tb02706.x.

    CAS  Article  PubMed  Google Scholar 

  85. Zone JJ, Meyer LJ, Petersen MJ. Deposition of granular IgA relative to clinical lesions in dermatitis herpetiformis. Arch Dermatol. 1996;132:912–918.

    CAS  PubMed  Google Scholar 

  86. Marks J. Small-bowel changes in dermatitis herpetiformis. Lancet. 1966;288:1280–1282.

    Google Scholar 

  87. Zhu YI, Stiller MJ. Dapsone and sulfones in dermatology: overview and update. J Am Acad Dermatol. 2001;45:420–434.

    CAS  PubMed  Google Scholar 

  88. Garioch JJ, Lewis HM, Sargent SA, Leonard JN, Fry L. 25 years’ experience of a gluten-free diet in the treatment of dermatitis herpetiformis. Br J Dermatol. 1994;131:541–545.

    CAS  PubMed  Google Scholar 

  89. Rodrigues F, Bachmeyer C. Coeliac disease and dermatitis herpetiformis. The Lancet. 2018;392:916.

    Google Scholar 

  90. Caproni M, Antiga E, Melani L, Fabbri P. Guidelines for the diagnosis and treatment of dermatitis herpetiformis. J Eur Acad Dermatol Venereol. 2009;23:633–638. https://doi.org/10.1111/j.1468-3083.2009.03188.x.

    CAS  Article  PubMed  Google Scholar 

  91. Roizen NJ, Patterson D. Down’s syndrome. Lancet. 2003;361(9365):1281–1289.

    PubMed  Google Scholar 

  92. Mårild K, Stephansson O, Grahnquist L, Cnattingius S, Söderman G, Ludvigsson JF. Down syndrome is associated with elevated risk of celiac disease: a nationwide case–control study. J Pediatr. 2013;163:237–242.

    PubMed  Google Scholar 

  93. Swigonski NL, Kuhlenschmidt HL, Bull MJ, Corkins MR, Downs SM. Screening for celiac disease in asymptomatic children with down syndrome: cost-effectiveness of preventing lymphoma. Pediatrics. 2006;. https://doi.org/10.1542/peds.2005-2123.

    Article  PubMed  Google Scholar 

  94. Bull MJ, Saal HM, Braddock SR, et al. Clinical report—health supervision for children with Down syndrome. Pediatrics. 2011;128:393–406.

    PubMed  Google Scholar 

  95. Sharr C, Lavigne J, Elsharkawi IMA, et al. Detecting celiac disease in patients with Down syndrome. Am J Med Genet A. 2016;170:3098–3105. https://doi.org/10.1002/ajmg.a.37879.

    Article  PubMed  Google Scholar 

  96. Bondy CA. Clinical practice guideline: care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group. J Clin Endocrinol Metab. 2007;92:10–25.

    CAS  PubMed  Google Scholar 

  97. Goldacre MJ, Seminog OO. Turner syndrome and autoimmune diseases: record-linkage study. Arch Dis Child. 2014;99:71–73.

    PubMed  Google Scholar 

  98. Mårild K, Størdal K, Hagman A, Ludvigsson JF. Turner syndrome and celiac disease: a case–control study. Pediatrics. 2016;137:20152232.

    Google Scholar 

  99. Rajani S, Huynh HQ, Turner J. The changing frequency of celiac disease diagnosed at the Stollery Children’s Hospital. Can J Gastroenterol. 2010;24. www.cdc.gov/epi.

  100. Migliarese Isaac D, Wu J, Mager DR, Turner JM. Managing the pediatric patient with celiac disease: a multidisciplinary approach. J Multidiscipl Healthc. 2016;. https://doi.org/10.2147/JMDH.S95323.

    Article  Google Scholar 

Download references

Acknowledgments

The authors thank Lubaina Ehsan for assistance with creating Fig. 1.

Author information

Authors and Affiliations

  1. Department of Medicine, Division of Gastroenterology and Hepatology, University of Virginia, 1215 Lee Street, PO Box 800708, Charlottesville, VA, 22908, USA

    Dennis Kumral

  2. Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, School of Medicine, University of Virginia, MR-4 Bldg, 409 Lane Rd., Charlottesville, VA, 22908, USA

    Sana Syed

Authors
  1. Dennis Kumral
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sana Syed
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dennis Kumral.

Ethics declarations

Conflict of interest

No authors have any conflicts of interest to report.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Kumral, D., Syed, S. Celiac Disease Screening for High-Risk Groups: Are We Doing It Right?. Dig Dis Sci 65, 2187–2195 (2020). https://doi.org/10.1007/s10620-020-06352-w

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-020-06352-w

Keywords

  • Celiac disease
  • Screening
  • Serology
  • Anti-tissue transglutaminase
  • High-risk populations
  • First-degree relatives
  • Type 1 diabetes mellitus
  • Autoimmune thyroid disease
  • Iron deficiency anemia